Femasys Inc.
Femasys Inc. (FEMY) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Femasys Inc. (FEMY), featuring income statements, balance sheets, and cash flow data.
Femasys Inc. (FEMY) Income Statement & Financial Overview
Analyze Femasys Inc.’s FEMY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $341264.00 | $581576.00 | $554908.00 | $221484.00 |
| Cost of Revenue | $117266.00 | $192407.00 | $190839.00 | $73125.00 |
| Gross Profit | $223998.00 | $389169.00 | $364069.00 | $148359.00 |
| Gross Profit Ratio | $0.66 | $0.67 | $0.66 | $0.67 |
| R&D Expenses | $2.97M | $2.17M | $2.30M | $1.98M |
| SG&A Expenses | $2.63M | $2.86M | $3.10M | $2.59M |
| Operating Expenses | $5.68M | $5.11M | $5.48M | $4.63M |
| Total Costs & Expenses | $5.80M | $5.30M | $5.67M | $4.70M |
| Interest Income | $19029.00 | $49504.00 | $124028.00 | $184138.00 |
| Interest Expense | $459449.00 | $440422.00 | $413290.00 | $388311.00 |
| Depreciation & Amortization | $217060.00 | $218255.00 | $215718.00 | $214135.00 |
| EBITDA | -$5.22M | -$4.45M | -$4.78M | -$4.08M |
| EBITDA Ratio | -$15.31 | -$7.66 | -$8.61 | -$18.44 |
| Operating Income | -$5.46M | -$4.72M | -$5.12M | -$4.48M |
| Operating Income Ratio | -$16.001 | -$8.12 | -$9.22 | -$20.24 |
| Other Income/Expenses (Net) | -$440420.00 | -$390918.00 | -$289262.00 | -$204173.00 |
| Income Before Tax | -$5.90M | -$5.11M | -$5.41M | -$4.69M |
| Income Before Tax Ratio | -$17.29 | -$8.79 | -$9.75 | -$21.16 |
| Income Tax Expense | -$4188.00 | $10194.00 | $1158.00 | -$1750.00 |
| Net Income | -$5.90M | -$5.12M | -$5.41M | -$4.68M |
| Net Income Ratio | -$17.28 | -$8.81 | -$9.75 | -$21.15 |
| EPS | -$0.23 | -$0.23 | -$0.24 | -$0.21 |
| Diluted EPS | -$0.23 | -$0.23 | -$0.24 | -$0.21 |
| Weighted Avg Shares Outstanding | $25.15M | $22.80M | $22.23M | $22.22M |
| Weighted Avg Shares Outstanding (Diluted) | $25.15M | $22.80M | $22.23M | $22.22M |
Financial performance has remained strong, with revenue growing from $221484.00 in Q2 2024 to $341264.00 in Q1 2025. Gross profit continued to perform well, with margins at 66% in the latest quarter. Operating income reached -$5.46M in Q1 2025, holding a steady -1600% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$5.22M. Net income dropped to -$5.90M, keeping EPS at -$0.23. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan